Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

ReportsWorldwide has announced the addition of a new report title Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential to its growing collection of premium market research reports.

Immunology is a large therapy area characterized by disorders of the immune system – specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead to various types of chronic pain and loss of mobility, and have a negative impact on quality of life.

Scope of the Report:

- What are the key points of overlap in the pathophysiology of immune disorders?

- What is the current standard of treatment across these markets, and what lessons can be learned by companies seeking to innovate and build on these products?

- Which molecule types and molecular targets are most prominent within the pipeline?

- Which first-in-class targets are most promising?

- Do immunology products attract high deal values, and which specific product types are able to attract the highest values?

- Which molecule types and molecular targets dominate the deals landscape?

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=6874

Reasons to buy

- Appreciate the current clinical and commercial landscapes by considering disease pathogenesis, etiology, epidemiology, symptoms, co-morbidities and complications, and treatment options.

- Identify leading products and companies within the market, as well as key unmet needs, in order to gain a competitive understanding of gaps in the market.

- Review key pipeline trends by analyzing therapies by stage of development, molecule type and molecular target, and identify key trends regarding innovation within each segment.

- Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, all first-in-class targets in the immunology pipeline have been assessed and ranked according to clinical potential, and the most promising early-stage targets have been further reviewed in greater detail.

- Identify promising first-in-class pipeline assets that have had no prior involvement in licensing or co-development deals, and are therefore potentially suitable for in-licensing.

To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/frontier-pharma-versatile-innovation-in-immunology-large-therapy-area-pipeline-with-a-high-degree-of-repositioning-potential

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.